IJEP 44(13): 1193-1200 : Vol. 44 Issue. 13 (Conference 2024)
1. Graphic Era (Deemed to be University), Department of Biotechnology, Dehradun – 248 002, Uttarakhand, India
2. Graphic Era (Deemed to be University), Department of Microbiology, Dehradun – 248 002, Uttarakhand, India
Abstract
Ganoderma lucidum, commonly known as Lingzhi or Reishi, is a renowned medicinal fungus with a rich history of enhancing health and extending life.G. lucidum holds great promise in the Himalayan region, where biodiversity preservation and sustainable resource management are priorities. First, growing this mushroom can relieve strain on ecologically fragile places by giving local residents another source of income. Additionally, in line with the region’s dedication to sustainability, the manufacturing of bioactive chemicals from G. lucidum can aid in the development of environmentally friendly goods like biodegradable plastics and natural insecticides. The goal of this review paper is to examine G.lucidum’s unrealized potential as a useful tool for managing natural resources and conserving biodiversity in the Himalayan region and will examine its bioactive components, therapeutic potentials and potential ecological advantages for nearby populations. The Himalayan region may make substantial progress towards striking the delicate balance between environmental preservation and socio-economic growth by utilizing the power of G. lucidum, assuring a sustainable future for future generations.
Keywords
Ganoderma lucidum, Reishi, Bioactive compounds, Biodiversity conservation, Sustainable resource
References
- Galor, S.W., et al. 2011. Ganoderma lucidum (Lingzhi or Reishi): A medicinal mushroom. In Herbal medicine: Biomolecular and clinical aspects (2nd edn). Ed I.F.F. Benzie and S.W. Galor. CRC Press/Taylor and Francis, Florida, U.S.A.
- Kim, S.S. and Y.B. Kim. 1980. A pictorial book of the Korean mushroom. Yoopung Press, Seoul. pp 298-299.
- Kim, M.J., et al. 1986. Studies on safety of Ganoderma lucidum. Korean J. Mycol., 14(1): 49-59.
- Rai, M., G. Tidke and S.P. Wasser. 2005. Therapeutic potential of mushrooms. Nat. Prod. Radiance. 4: 246-257.
- Sanodiya, B.S., et al. 2009. Ganoderma lucidum: A potent pharmacological macrofungus. Curr. Pharm. Biotech., 10: 717-742.
- Wu, S., et al. 2024. Ganoderma lucidum: A comprehensive review of phytochemistry, efficacy, safety and clinical study. Food Sci. Human Well-ness. 13(2): 568-596.
- Matute, R.G., et al. 2011. Copper and zinc bio-accumulation and bioavailability of Ganoderma lucidum. J. Med. Food. 14: 1273-1279.
- Falandysz, J. 2008. Selenium in edible mushrooms. J. Env. Sci. Health Part C. Env. Carcinog. Ecoto-xicol. Rev., 26: 256-299.
- Hu, Y., et al. 2022. Immunomodulatory effect of Ganoderma lucidum polysaccharides extract on potenial macrophage function of BALB/c mice. Cell Mol. Biol., 68(4): 31-34.
- Tang, Y., et al. 2009. Immunomodulatory effects of Ganoderma lucidum polysaccharides: A review of its structure functions and mechanisms. Int. J. Biol. Macromol., 121: 1092-1096.
- Wang, J., et al. 2014. Structure and immuno-modulatory activity of a water soluble polysaccharide from Ganoderma lucidum. Carbohydr. Polym., 111: 657-663.
- Li, L., et al. 2016. Anti-inflammatory activity of polysaccharide extracted from Ganoderma luci-dum. Int. J. Biol. Macromol., 92: 942-946.
- Yuan, J., et al. 2008. Purification and antitumour activity of polysaccharides from Ganoderma lucidum. J. Pharma. Sci., 97(9): 3936-3947.
- Gao, X., et al. 2020. Structural characterization and immunomodulatory activity of a water soluble polysaccharide from Ganoderma leucocontextum fruiting bodies. Carbohydr. Polym., 249: 116874.
- Wu, Q.P., et al. 2016. Ergostrol peroxide isolated from Ganoderma lucidum abolishes micro RNA miR 378-mediated tumor cells on chemoresistance. PLoS One. 7(8): e44579.
- Jedinak, A., et al. 2014. Ganodermanontrol, a lanostanoid triterpene from Ganoderma lucidum suppresses growth of colon cancer cells through b-catenin signaling. Int. J. Oncol., 45(5): 2007-2012.
- Khan, S., et al. 2015. Suppression of LPS-induced inflammatory and NF-kB responses by anomalin in RAW 264.7 macrophages. J. Cell Biochem., 112(8): 2179-2188.
- Wu, G.S., et al. 2019. Ganoderiol A-enriched extract suppresses migration and adhesion of MDA-MB-231 cells by inhibiting FAK-SRC-paxillin cascade pathway. PLoS One. 8(10): e76620.
- Sun, Y., et al. 2015. Ganoderic acid T from Ganoderma lucidum suppresses the growth of prostate cancer cells through induction of apoptosis and modulation of the androgen receptor pathway. J. Natr. Prod., 78(8):1937-1945.
- Liu, J., et al. 2017. Ganoderic acid A attenuates cognitive dysfunction in APP/PS1 transgenic mice via inhibition of amyloidogenesis and neuroinflam-mation. J. Ethnopharmacol., 198: 466-477.
- Chen, J., et al. 2018. Ganoderic acid DM, an active triterpene from Ganoderma lucidum, attenuates non-alcoholic fatty liver disease and hyperglycemia in db/db mice. J. Agric. Food. Chem., 66 (26): 6631-6641.
- Li, W., et al. 2015. Lucidenic and B inhibits the inflammatory response by activating the Nrf2 pathway in macrophages and improves and survival of septic mice. J. Agric. Food Chem., 63(31):6799-6806.
- Jiang, J., et al. 2012. Lucidenic acid C, a new dterpene isolated from the fruiting bodies of Ganoderma lucidum protects against 6 hydoxydopamine induced neuro-toxicity in-vitro and in-vivo. J. Agric. Food Chem., 60(17):4238-4244.
- Wang, S.Y., et al. 2013. Lucidenic acid A activates the immune response in murine macrophages via the TLR4/MyD88 signaling pathway. J. Agric. Food Chem., 61(38):9104-9112.
- Gao, Y. 2003. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced stage cancer patients. Immunol. Invest., 32(3): 201-215.
- Kozarski, M., et al. 2011. Antioxidative and immuno-modulating activities of polysaccharide extracts of the medicinal mushrooms Agaricus bisporus, Agaricus brasiliensis, Ganoderma lucidum and Phellinus linteus. Food Chem., 129(4): 1667-1675.
- Oke, M.A., et al. 2022. Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging disease in Africa. Frontier Pharmacol., 13: 952027.
- Bach, J.P., et al. 2009. The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumours. Cancer. 115: 2031-2040.
- Mantovani, A. and A. Sica. 2010. Macrophages, innate immunity and cancer: Balance, tolerance and diversity. Curr. Opin. Immunol., 22: 231-237.
- Chang, Y.W. and T.J. Lu. 2004. Molecular characterization of polysaccharides in hot-water extracts of Ganoderma lucidum fruiting bodies. J. Food Drug Anal., 12(1): 59-67.
- Pan, D., et al. 2013. Antidiabetic, antihyper-lipidemic and antioxidant activities of a novel proteoglycan from Ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism. PLoS One. 8(7): e68332.
- Sun, L.X., et al. 2011a. Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells. J. Pharm. Pharmacol., 63: 725-735.
- Wang, C.L., et al. 2014. Activation of antitumor immune responses by Ganoderma formosanium polysaccharides in tumor-bearing mice. Appl. Microbiol. Biotech., 98: 9389-9398.
- Karwa, A. and M. Rai. 2012. Naturally occurring medicinal mushroom-derived antimicrobials: A case study using lingzhi or reishi Ganoderma lucidum (W. Curt.:Fr.) P. Karst (higher Basidiomycetes). Int. J. Med. Mushrooms. 14: 481-490.
- Yoon, S.Y., et al. 1994. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch. Pharm. Res., 17: 438-432.
- Vazirian, M., et al. 2014. Antimicrobial effect of the Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (higher Basidiomycetes) and its main compounds. Int. J. Med. Mushrooms. 16: 77-84.
- Shi, L., et al. 2010. Current progress in the study on biosynthesis and regulation of ganoderic acids. Appl. Microbiol. Biotech., 88(6): 1243-1251.
- Su, C.H., et al. 2001. High performance liquid chromatographic analysis for the characterization of triterpenoids from Ganoderma. J. Chromatogr. Sci., 39(3): 93-100.
- Bielawski, K., et al. 2008. Proline-linked nitroso-ureas as prodidase convertible prodrugs in human breast cancer cells. Pharmacol. Rep., 60(2): 171-182.
- Chen, N.H., J.W. Liu and J.J. Zhong. 2008. Genodaric acid Me inhibits tumor invasion through down regulating matrix metallo proteinases 2/9 gene expression. J. Pharmacol. Sci., 108(2): 212-216.
- Chen, N.H., J.W. Liu and J.J. Zhong. 2010. Genodaric acid T inhibits tumor invasion in-vitro and in-vivo through inhibition of MMP expression. Pharmacol. Rep., 62(1): 150-163.
- Brown, N.S., et al. 2000. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of anginogenic factor. Cancer Res., 60(22): 6298-6302.
- Freund, A., et al. 2003. IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene. 22 (2): 256-265.
- Bendre, M.S., et al. 2002. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in-vivo. Cancer Res., 62(19): 5571-5579.
- Thyagarajan, A., et al. 2006. Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Int. J. Mol. Med., 18(4): 657-664.
- Yuen, J.W. and M.D. Gehel. 2005. Anticancer effects of Ganoderma lucidum- A review of scientific evidence. Nutr. Cancer. 53(1): 11-17.
- Sone, Y., et al. 1985. Structure and antitumor activities of polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agric. Biol. Chem., 49: 2641-2653.
- Upton, R., et al. 2004. Anti-angioganic and inhibitory activity of inducible nitric oxide production of the mushroom Ganoderma lucidum: Standards of analysis, quality control and therapeutics. American Herbal Pharmacopoeia, U.S.A.
- Song, Y.S., et al. 2004. Anti-angioganic and inhibitory activity of inducible nitric oxide production of the mushroom Ganoderma lucidum. J. Ethnophar-macol., 90(1): 17-20.
- Cao, O.Z. and Z.B. Lin. 2006. Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer. Life Sci., 78(13): 1457-1463.
- Stanley, G., et al. 2005. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem. Biophys. Res. Comm., 330(1): 46-52.
- Hikino, H., et al. 1989. Mechanisms of hypoglycemic activity of ganoderan B: A glycan of Gano-derma lucidum fruit body. Planta. Med., 55: 423-428.
- Hikino, H., et al. 1985. Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganderma lucidum fruit bodies. Planta. Med., 4: 339-340.
- Combs, A.P. 2010. Recent advances in the discovery of competitive protein tyrosine phosphatase 1 B inhibitors for the treatment of diabetes, obesity and cancer. J. Med. Chem., 53(6): 2333-2344.
- Feldhammer, M., et al. 2013. PTP 1 B: A simple enzyme for a complex world. Crit. Rew. Biochem. Mol. Biol., 48(5): 430-445.
- Fatmawati, S., et al. 2011a. Ganoderol B: A potent alphaglucosidase inhibitor isolated from the fruting body of Ganoderma lucidum. Phytomed., 18(12): 1053-1055.
- Cilerdzic, J., et al. 2014. Biological activity of Ganoderma lucidum basidiocarps cultivated on alternative and commercial substrate. J. Ethnophar-macol., 155: 312-319.
- Sa-Ard, P., et al. 2015. Antioxidant, antibacterial and DNA protective activities of proteins extracts from Ganoderma lucidum. J. Food Sci. Tech., 52: 2966-2973.
- Heleno, S.A., et al. 2013. Antimicrobial and demelanizing activity of Ganoderma lucidum extract, p-hydroxy benzoic and cinnamic acids and their synthetic acetylated glucuronide methyl esters. Food Chem. Toxicol., 58: 95-100.
- Li, Y., et al. 2006. Antihepatitis activities in the broth of Ganoderma lucidum supplemented with a Chinese herbal medicine. American J. Chin. Med., 34: 341-349.
- Chang, S.T. and J.A. Buswell. 2008. Safety, quality control and regulation aspects relating to mushroom nutriceuticals. 6th International Conference on Mushroom biology and mushroom products. Proceedings, pp 188-195.
